Companies/US/CUE

CUE BIOPHARMA, INC.

Income flow

Annual
CUE 10-K Income StatementPeriod 2025-12-31Source 10-K
Net sales$27M+196% Y/YRevenue$27M+196% Y/YGross profit$26MCost of revenue$1M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0Shares outTotal shares currently outstanding (issued and not retired).7.3MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).6.4M
Stock splits
  1. 1:302026-04-24